183 related articles for article (PubMed ID: 26496292)
1. Extent of Serosal Changes Predicts Peritoneal Recurrence and Poor Prognosis After Curative Surgery for Gastric Cancer.
Kang Y; Li S; Ge Q; Liu X; Yang Z; Xue Y; Wang F
Medicine (Baltimore); 2015 Oct; 94(42):e1750. PubMed ID: 26496292
[TBL] [Abstract][Full Text] [Related]
2. Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.
Yoo C; Ryu MH; Park YS; Yoo MW; Park SR; Ryoo BY; Jang SJ; Yook JH; Kim BS; Kang YK
Ann Surg Oncol; 2015 Sep; 22(9):2940-7. PubMed ID: 25605515
[TBL] [Abstract][Full Text] [Related]
3. Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery.
Sun Z; Xu YY; Wang ZN; Zhu Z; Zhang H; Huang BJ; Xu Y; Chen JQ; Xu HM
Ann Surg Oncol; 2011 Apr; 18(4):1068-80. PubMed ID: 21293933
[TBL] [Abstract][Full Text] [Related]
4. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study.
Roukos DH; Lorenz M; Karakostas K; Paraschou P; Batsis C; Kappas AM
Br J Cancer; 2001 Jun; 84(12):1602-9. PubMed ID: 11401312
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
6. Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence.
Miki Y; Yashiro M; Ando K; Okuno T; Kitayama K; Masuda G; Tamura T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Osawa M; Hirakawa K; Ohira M
Surg Oncol; 2017 Dec; 26(4):352-358. PubMed ID: 29113652
[TBL] [Abstract][Full Text] [Related]
7. Development of a risk-scoring system to evaluate the serosal invasion for macroscopic serosal invasion positive gastric cancer patients.
Wang PL; Huang JY; Zhu Z; Gong BC; Huang HW; Duan SJ; Xu HM; Liu FN
Eur J Surg Oncol; 2018 May; 44(5):600-606. PubMed ID: 29454557
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer.
Boku T; Nakane Y; Minoura T; Takada H; Yamamura M; Hioki K; Yamamoto M
Br J Surg; 1990 Apr; 77(4):436-9. PubMed ID: 2340396
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with peritoneal metastasis in non-serosa-invasive gastric cancer: a retrospective study of a prospectively-collected database.
Huang B; Sun Z; Wang Z; Lu C; Xing C; Zhao B; Xu H
BMC Cancer; 2013 Feb; 13():57. PubMed ID: 23379700
[TBL] [Abstract][Full Text] [Related]
11. Magnitude of serosal changes predicts peritoneal recurrence of gastric cancer.
Bando E; Kawamura T; Kinoshita K; Takahashi S; Maeda A; Osada S; Tsubosa Y; Yamaguchi S; Uesaka K; Yonemura Y
J Am Coll Surg; 2003 Aug; 197(2):212-22. PubMed ID: 12892799
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence.
Deng J; Liang H; Sun D; Zhang R; Zhan H; Wang X
Can J Gastroenterol; 2008 Oct; 22(10):835-9. PubMed ID: 18925308
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma.
Chen CY; Wu CW; Lo SS; Hsieh MC; Lui WY; Shen KH
Hepatogastroenterology; 2002; 49(45):874-7. PubMed ID: 12064011
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy.
Aoyama T; Yoshikawa T; Hayashi T; Kuwabara H; Mikayama Y; Ogata T; Cho H; Tsuburaya A
Ann Surg Oncol; 2012 May; 19(5):1568-74. PubMed ID: 22143578
[TBL] [Abstract][Full Text] [Related]
15. Differences in risk factors between patterns of recurrence in patients after curative resection for advanced gastric carcinoma.
Nakanishi Y; Ohara M; Domen H; Shichinohe T; Hirano S; Ishizaka M
World J Surg Oncol; 2013 May; 11():98. PubMed ID: 23683476
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of exosomal miR‑29s in peritoneal fluid is a useful predictor of peritoneal recurrence after curative resection of gastric cancer with serosal involvement.
Ohzawa H; Saito A; Kumagai Y; Kimura Y; Yamaguchi H; Hosoya Y; Lefor AK; Sata N; Kitayama J
Oncol Rep; 2020 Apr; 43(4):1081-1088. PubMed ID: 32323853
[TBL] [Abstract][Full Text] [Related]
17. Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer.
Togano S; Yashiro M; Miki Y; Yamamoto Y; Sera T; Kushitani Y; Sugimoto A; Kushiyama S; Nishimura S; Kuroda K; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Tanaka S; Ohira M
PLoS One; 2020; 15(1):e0225958. PubMed ID: 31940352
[TBL] [Abstract][Full Text] [Related]
18. Proposal of a risk score for recurrence in patients with curatively resected gastric cancer.
Ichikura T; Fujino K; Ikawa H; Tomimatsu S; Uefuji K; Tamakuma S
Surg Today; 1993; 23(9):759-64. PubMed ID: 8219607
[TBL] [Abstract][Full Text] [Related]
19. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
20. The pattern and risk factors of recurrence of proximal gastric cancer after curative resection.
Li F; Zhang R; Liang H; Liu H; Quan J
J Surg Oncol; 2013 Feb; 107(2):130-5. PubMed ID: 22949400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
